期刊文献+

姜黄素偶联O-羧甲基壳聚糖纳米粒的制备及抗癌活性考察 被引量:5

Preparation and Anticancer Activity Investigation of Curcumin Conjugated O-Carboxymethyl Chitosan Nanoparticles
原文传递
导出
摘要 目的:制备姜黄素偶联O-羧甲基壳聚糖纳米粒(Cur-OMCS)并考察其对HepG2细胞的抑制能力。方法:通过酯化反应将姜黄素和O-羧甲基壳聚糖键合在一起,利用紫外、红外、核磁及透射电镜对Cur-OMCS进行表征,通过MTT考察CurOMCS对肿瘤细胞的抑制效果。结果:Cur-OMCS在水中自组装成纳米粒,平均粒径319 nm,粒径分布指数0.488,Zeta电势-26.1 mV,水溶液呈黄色澄清透明,姜黄素在水中质量浓度提高了300倍。姜黄素载药量1.5%,Cur-OMCS的临界胶束质量浓度0.040 g·L-1,Cur-OMCS对HepG2细胞的抑制效果明显优于游离姜黄素,当Cur-OMCS中姜黄素质量浓度15 mg·L-1时,细胞生长抑制率达80%。结论:Cur-OMCS在水中可自组装形成纳米粒子,极大地提高了姜黄素的肿瘤细胞抑制能力。 Objective: To prepare curcumin conjugated O-carboxymethyl chitosan nanoparticles (Cur- OMCS) and investigate its ability to inhibit HepG2 cells. Method: Curcumin was conjugated to O-carboxymethyl ehitosan by esterification reaction. Cur-OMCS was measured by UV-Vis, IR, NMR and TEM. Antieancer activity of Cur-OMCS was investigated by MTT. Result: Cur-OMCS could form nanoparticles by self-assembly in aqueous media with average particle size of 319 nm, partiele size distribution index of 0. 488, Zeta potential of-26. 1 mV and drug loading of 1.5%. The solution showed clear and transparent with yellow. The concentration of curcumin in aqueous media increased 300 times with critical micelle concentration of 0. 040 g ·L^-1. The inhibitory effect on HepG2 cells of Cur-OMCS was much better than that of free curcumin with the cell proliferation inhibition rate of 80% when the concentration of curcumin reached 15 mg ·L^-1. Conclusion: Self-assembled nanopartieles of eureumin conjugated O-carboxymethyl chitosan increased antieancer activity of cureumin.
作者 武莹 杨建设
出处 《中国实验方剂学杂志》 CAS 北大核心 2013年第19期1-4,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 中国科学院"西部之光"项目(Y00420KXG1)
关键词 姜黄素 O-羧甲基壳聚糖 自组装 纳米粒子 HEPG2细胞 临界胶束质量浓度 micelle concentrationcurcumin O-carboxymethyl chitosan self-assemble nanoparticles HepG2 cells critical
  • 相关文献

参考文献13

  • 1Aggarwal B B, Harikumar K B. Potential therapeutic effects of curcumin, the anti-inflammatory agent,against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases [ J ]. Int J Biochem Cell Biol,2009,41 ( 1 ) :40. 被引量:1
  • 2Lao C D,Ruffin M T, Normolle D, et al. Dose escalation of a curcuminoid formulation [ J ]. BMC Complementary Altern Med,2006,6( 1 ) :10. 被引量:1
  • 3Anand P, Kunnumakkara A B, Newman R A, et al. Bioavailability of curcumin : problems and promises [ J ]. Mol Pharmacol,2007,4 (6) :807. 被引量:1
  • 4Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent:review of the gap between basic and clinical applications [ J ]. Curr Med Chem, 2010, 17 (3) :190. 被引量:1
  • 5Anand P, Nair H B, Sung B K, et al. Design of curcumin- loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo [ J ]. Biochem Pharmacol, 2010,79(3) :330. 被引量:1
  • 6Yallapu M M, Jaggi M, Chauhan S C. Beta-cyclodextrin- curcumin self-assembly enhances curcumin delivery in prostate cancer cells [ J ]. Colloids Surf B, 2010, 79 (1) :113. 被引量:1
  • 7Safavy A, Raisch K P, Mantena S, et al. Design and development of water-soluble curcumin conjugates as potential anticancer agents [ J ]. J Med Chem, 2007,50 (24) :6284. 被引量:1
  • 8ZHANG F, Koh G Y, Jeansonne D P, et al. A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity [ J ]. J Pharm Sci,2011 , 100 ( 7 ) :2778. 被引量:1
  • 9林晓洁,张华,金少钢,张雯.盐酸青藤碱壳聚糖纳米粒的制备及体外释放性能的研究[J].中国实验方剂学杂志,2011,17(4):22-25. 被引量:11
  • 10童文婷,刘波,张睿,徐彭,管咏梅,聂斌,谈伟锋.雷公藤甲素叶酸-壳聚糖纳米粒的制备及其释药性能考察[J].中国实验方剂学杂志,2012,18(22):49-52. 被引量:7

二级参考文献23

  • 1王岩,丛振娜,刘清飞,凌家俊,周莉玲.青藤碱脂质体的处方优化及制备工艺研究[J].中国中药杂志,2009,34(3):275-278. 被引量:10
  • 2郝英魁,杨学东.载药壳聚糖纳米粒的研究进展[J].中国药学杂志,2005,40(17):1292-1295. 被引量:30
  • 3柳时,徐喆,罗智,项光亚.叶酸偶联壳聚糖纳米粒的制备[J].医药导报,2006,25(6):561-563. 被引量:21
  • 4林爱华,平其能.壳聚糖载药纳米粒研究进展[J].中国药业,2006,15(21):25-27. 被引量:12
  • 5Agnihotri S A, Mallikarjuna N N, Aminabhavi T M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery [ J ]. J Controlled Release, 2004,100 ( 1 ) : 26. 被引量:1
  • 6Behrens I, Pena A I, Atonso M J,et al. Comparative uptake studies of bioadhensive and non-bioadhensive nanoparticles in human intestinal cell lines and rats:the effect of mucus on particle adsorption and transport [ J ]. Pharmaceutical Research ,2002,19 ( 8 ) : 1185. 被引量:1
  • 7Wang W ,Yang S, Su Y ,et al. Enhanced antitumor effect of combined triptolide and ionizing radiation [ J ]. Clin Cancer Res ,2007,13 ( 16 ) :4891. 被引量:1
  • 8Leuenroth S J, Okuhara D ,Shotwell J D, et al. Triptolide is a traditional chinese medicine-derived inhibitor of polycystic kidney disease[J]. Proc Natl Acad Sci USA, 2007,104( 11 ) :4389. 被引量:1
  • 9Xu L, Chen H, Xu H, Yang X. Anti-tumour and immune- modulation effects of triptolide-loaded polymeric micelles [ J]. Eur J Pharm Biopharm,2008,70(3) :741. 被引量:1
  • 10Meier R, Henning T D, Boddington S, et al. Breast cancer: MR imaging of folate-receprot expression with the folate-specific nanoparticle Pl133 [ J ]. Radiology, 2010, 255(2) :527. 被引量:1

共引文献16

同被引文献92

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部